Literature DB >> 12507911

Experimental glomerulopathy alters renal cortical cholesterol, SR-B1, ABCA1, and HMG CoA reductase expression.

Ali C M Johnson1, Julie M Yabu, Sherry Hanson, Vallabh O Shah, Richard A Zager.   

Abstract

Previous studies indicate that acute tubular injury causes free cholesterol (FC) and cholesteryl ester (CE) accumulation within renal cortex/proximal tubules. This study assessed whether similar changes occur with glomerulopathy/nephrotic syndrome, in which high-circulating/filtered lipoprotein levels increase renal cholesterol supply. Potential adaptive changes in cholesterol synthetic/transport proteins were also assessed. Nephrotoxic serum (NTS) or passive Heymann nephritis (PHN) was induced in Sprague-Dawley rats. Renal injury (blood urea nitrogen, proteinuria) was assessed 2 and 7 days (NTS), or 10 and 30 days (PHN) later. FC and CE levels in renal cortex, isolated glomeruli, and proximal tubule segments were determined. SR-B1 (a CE influx protein), ABCA1 (a FC exporter), and HMG CoA reductase protein/mRNA levels were also assessed. FC was minimally elevated in renal cortex (0 to 15%), the majority apparently localizing to proximal tubules. More dramatic CE elevations were found ( approximately 5 to 15x), correlating with the severity of proteinuria at any single time point (r >/= 0.85). Cholesterol increments were associated with decreased SR-B1, increased ABCA1, and increased HMG CoA reductase (HMGCR) protein and its mRNA. Tubule (HK-2) cell culture data indicated that SR-B1 and ABCA1 levels are responsive to cholesterol supply. Experimental nephropathy can increase renal FC, and particularly CE, levels, most notably in proximal tubules. These changes are associated with adaptations in SR-B1 and ABCA1 expression, which are physiologically appropriate changes for a cholesterol overload state. However, HMGCR protein/mRNA increments can also result. These seem to reflect a maladaptive response, potentially contributing to a cell cholesterol overload state.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507911      PMCID: PMC1851117          DOI: 10.1016/S0002-9440(10)63819-9

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.

Authors:  B L Kasiske; M P O'Donnell; W J Garvis; W F Keane
Journal:  Circ Res       Date:  1988-02       Impact factor: 17.367

2.  Anti-GBM antibody-induced proteinuria in isolated perfused rat kidney.

Authors:  W G Couser; C Darby; D J Salant; S Adler; M M Stilmant; L M Lowenstein
Journal:  Am J Physiol       Date:  1985-08

3.  Induction of glomerulosclerosis by dietary lipids. A functional and morphologic study in the rat.

Authors:  H J Gröne; A Walli; E Gröne; P Niedmann; J Thiery; D Seidel; U Helmchen
Journal:  Lab Invest       Date:  1989-03       Impact factor: 5.662

4.  Altered cholesterol localization and caveolin expression during the evolution of acute renal failure.

Authors:  Richard A Zager; Ali Johnson; Sherry Hanson; Vivian dela Rosa
Journal:  Kidney Int       Date:  2002-05       Impact factor: 10.612

5.  The mevalonate pathway during acute tubular injury: selected determinants and consequences.

Authors:  Richard A Zager; Vallabh O Shah; Hemangini V Shah; Philip G Zager; Ali C M Johnson; Sherry Hanson
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

6.  Plasma volume expansion is necessary for edema formation in the rate with Heymann nephritis.

Authors:  G A Kaysen; T T Paukert; D J Menke; W G Couser; M H Humphreys
Journal:  Am J Physiol       Date:  1985-02

7.  Glomerulopathy does not increase renal susceptibility to acute ischemic injury.

Authors:  R A Zager; L A Baltes; H M Sharma; W G Couser
Journal:  Am J Physiol       Date:  1984-03

8.  Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome.

Authors:  K P Harris; M L Purkerson; J Yates; S Klahr
Journal:  Am J Kidney Dis       Date:  1990-01       Impact factor: 8.860

9.  Mevalonolactone inhibits the rate of synthesis and enhances the rate of degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in rat hepatocytes.

Authors:  P A Edwards; S F Lan; R D Tanaka; A M Fogelman
Journal:  J Biol Chem       Date:  1983-06-25       Impact factor: 5.157

10.  Cholestyramine resin ameliorates chronic aminonucleoside nephrosis.

Authors:  J R Diamond; N A Hanchak; M D McCarter; M J Karnovsky
Journal:  Am J Clin Nutr       Date:  1990-04       Impact factor: 7.045

View more
  11 in total

1.  HMG-CoA reductase activation and urinary pellet cholesterol elevations in acute kidney injury.

Authors:  Ali Cm Johnson; Lorraine B Ware; Jonathan Himmelfarb; Richard A Zager
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-28       Impact factor: 8.237

2.  Anthocyanins and phenolic acids from a wild blueberry (Vaccinium angustifolium) powder counteract lipid accumulation in THP-1-derived macrophages.

Authors:  Cristian Del Bo'; Yi Cao; Martin Roursgaard; Patrizia Riso; Marisa Porrini; Steffen Loft; Peter Møller
Journal:  Eur J Nutr       Date:  2015-01-17       Impact factor: 5.614

Review 3.  HDL metabolism and activity in chronic kidney disease.

Authors:  Nosratola D Vaziri; Mohamad Navab; Alan M Fogelman
Journal:  Nat Rev Nephrol       Date:  2010-03-23       Impact factor: 28.314

4.  Albumin-induced apoptosis of glomerular parietal epithelial cells is modulated by extracellular signal-regulated kinase 1/2.

Authors:  Alice M Chang; Takamoto Ohse; Ron D Krofft; Jimmy S Wu; Allison A Eddy; Jeffrey W Pippin; Stuart J Shankland
Journal:  Nephrol Dial Transplant       Date:  2011-09-05       Impact factor: 5.992

5.  High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney.

Authors:  Hyun Ju Kim; Jun Yuan; Keith Norris; Nosratola D Vaziri
Journal:  J Nutr Biochem       Date:  2009-12-01       Impact factor: 6.048

6.  Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney.

Authors:  Hyun Ju Kim; Hamid Moradi; Jun Yuan; Keith Norris; Nosratola D Vaziri
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-08

7.  Acute tubular injury causes dysregulation of cellular cholesterol transport proteins.

Authors:  Richard A Zager; Ali C M Johnson; Sherry Y Hanson; Vallabh O Shah
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

8.  Cellular cholesterol transport proteins in diabetic nephropathy.

Authors:  Joseph G S Tsun; Susan Yung; Mel K M Chau; Sammy W M Shiu; Tak Mao Chan; Kathryn C B Tan
Journal:  PLoS One       Date:  2014-09-02       Impact factor: 3.240

Review 9.  Metabolism, energetics, and lipid biology in the podocyte - cellular cholesterol-mediated glomerular injury.

Authors:  Sandra Merscher; Christopher E Pedigo; Armando J Mendez
Journal:  Front Endocrinol (Lausanne)       Date:  2014-10-14       Impact factor: 5.555

10.  Transcript-specific expression profiles derived from sequence-based analysis of standard microarrays.

Authors:  Anton G Moll; Maja T Lindenmeyer; Matthias Kretzler; Peter J Nelson; Ralf Zimmer; Clemens D Cohen
Journal:  PLoS One       Date:  2009-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.